Fine Particulate Matter and Markers of Alzheimer’s Disease Neuropathology at Autopsy in a Community-Based Cohort | Zendy

Rachel M. Shaffer | Zendy; Ge Li | Zendy; Sara D. Adar | Zendy; C. Dirk Keene | Zendy; Caitlin S. Latimer | Zendy; Paul K. Crane | Zendy; Eric B. Larson | Zendy; Joel D. Kaufman | Zendy; Marco Carone | Zendy; Lianne Sheppard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fine Particulate Matter and Markers of Alzheimer’s Disease Neuropathology at Autopsy in a Community-Based Cohort

Author(s) -

Rachel M. Shaffer,

Ge Li,

Sara D. Adar,

C. Dirk Keene,

Caitlin S. Latimer,

Paul K. Crane,

Eric B. Larson,

Joel D. Kaufman,

Marco Carone,

Lianne Sheppard

Publication year - 2021

Publication title -

journal of alzheimer s disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.677

H-Index - 139

eISSN - 1875-8908

pISSN - 1387-2877

DOI - 10.3233/jad-201005

Subject(s) - neuropathology , autopsy , cohort , alzheimer's disease , medicine , particulates , disease , pathology , psychology , biology , ecology

Evidence links fine particulate matter (PM2.5) to Alzheimer's disease (AD), but no community-based prospective cohort studies in older adults have evaluated the association between long-term exposure to PM2.5 and markers of AD neuropathology at autopsy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research